Additionally, aspirin has been shown to inhibit ESCC progression by downregulating the ATAD2/KIF4A axis [83]; while etoposide ameliorates psoriasis and Crohn’s comorbidity by regulating KIF4A [125]. Here, KIF4A is linked to psoriasis.